WealthPlan Investment Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
DG
WealthPlan Investment Management's HCAT Position: Q2 2023 in Review
WealthPlan Investment Management sold out of Health Catalyst (HCAT) in Q2 2023, closing a stake of 3,326 shares — an estimated $38.8K sold.
WealthPlan Investment Management first reported a position in HCAT in Q1 2023 and held it in 1 quarter. The position peaked at $38.8K in Q1 2023. 154 funds tracked by Wall St. Rank hold HCAT as of Q2 2023.
- WealthPlan Investment Management reported no remaining Health Catalyst position as of Q2 2023 after selling out during the quarter.
- WealthPlan Investment Management sold 3,326 Health Catalyst shares in Q2 2023, an estimated $38.8K.
- WealthPlan Investment Management first reported a position in Health Catalyst in Q1 2023 and held it in 1 quarter.
- WealthPlan Investment Management's Health Catalyst position peaked at $38.8K in Q1 2023.
- 154 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2023.
Based on WealthPlan Investment Management's 13F filing for Q2 2023, filed 25 Jul 2023.